Health-related quality of life in hereditary angioedema patients treated with subcutaneous C1 inhibitor (C1-INH) therapy in Canada
Overall, patients on long-term prophylaxis with SC-pdC1INH reported improvements in many HR-QoL domains, but most significantly relief of stress and anxiety associated with HAE, and improvement in social and physical well-being.
Authors
- Amin Kanani (ORCID: https://orcid.org/0000-0002-2081-9318)
- Harold Kim (ORCID: https://orcid.org/0000-0002-0497-844X)
- Gina Lacuesta
- Hugo Chapdelaine (ORCID: https://orcid.org/0000-0001-6256-0271)
- Belinda Yap (ORCID: https://orcid.org/0000-0001-7792-2474)
- Gordon Sussman (ORCID: https://orcid.org/0000-0002-2202-2513)
- Paul K. Keith (ORCID: https://orcid.org/0000-0002-5644-1855)
- Chrystyna Kalicinsky
- Adil Adatia (ORCID: https://orcid.org/0000-0002-7612-6529)
- Adriana Martin
- Susan Waserman
- Hachem Mahfouz
- Marie-France Dansereau
- Nataly Tanios
- Rami El-Sayegh
- Maye Machnouk
- Hadi A Goubran Messiha
Institutions
- Western University (CA)
- Dalhousie University (CA)
- University of British Columbia (CA)
- University of Alberta (CA)
- University of Toronto (CA)
- University of Saskatchewan (CA)
- Saskatchewan Cancer Agency (CA)
- University of Manitoba (CA)
- McMaster University (CA)
Publication Details
- Journal
- Allergy Asthma and Clinical Immunology
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1186/s13223-025-00991-2
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 0.00